Elkfork Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Elkfork Partners’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.18M	Hold	3,536	–	–	0.03%	349
2019 Q2	$1.1M	Hold	3,536	–	–	0.03%	374
2019 Q1	$1.08M	Sell	3,536 -680	-16%	-$184K	0.03%	361
2018 Q4	$979K	Sell	4,216 -170	-4%	-$45.6K	0.03%	354
2018 Q3	$1.37M	Buy	4,386 +1,496	+52%	+$464K	0.03%	321
2018 Q2	$834K	Hold	2,890	–	–	0.02%	385
2018 Q1	$723K	Hold	2,890	–	–	0.02%	425
2017 Q4	$690K	Buy	2,890 +272	+10%	+$65.9K	0.02%	444
2017 Q3	$582K	Buy	2,618 +306	+13%	+$68.9K	0.02%	451
2017 Q2	$523K	Buy	2,312 +952	+70%	+$207K	0.02%	485
2017 Q1	$271K	Buy	1,360 +204	+18%	+$39.3K	0.01%	549
2016 Q4	$211K	Buy	+1,156	New	+$197K	0.01%	557

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Elkfork Partners's BIO Position: Q3 2019 in Review

Elkfork Partners held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2019 at 3,536 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #349.

Elkfork Partners first reported a position in BIO in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.37M in Q3 2018. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

Elkfork Partners held 3,536 shares of Bio-Rad Laboratories Class A worth $1.18M as of Q3 2019.
Elkfork Partners left its Bio-Rad Laboratories Class A share count unchanged in Q3 2019.
Bio-Rad Laboratories Class A made up 0.03% of Elkfork Partners's portfolio in Q3 2019, its #349 holding.
Elkfork Partners first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Bio-Rad Laboratories Class A position peaked at $1.37M in Q3 2018.
355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.